4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001628280-24-001424
Director sold 3,934 shares at an average $38.07 ($149,759)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Waddill William D. Director | 2024-01-11 | Sale 10b5-1 | −2,634 | $37.81 | $99,592 | 49,170 | D |
| Waddill William D. Director | 2024-01-11 | Sale 10b5-1 | −1,300 | $38.59 | $50,167 | 47,870 | D |
| Open-market sales · 3,934 sh · avg $38.07 · $149,759 | |||||||
Loading xslF345X05/wk-form4_1705446389.xml…